Cell and Tissue Preservation Market Size, Trends, Analysis, and Outlook By Preservation Technique (Cryopreservation, Hypothermic Preservation), By Product (Equipment and Consumables, Laboratory Information Management Systems (LIMS), Accessories (vials, containers, labels), By Application (Organ Transplantation:, Regenerative Medicine, Biobanking, Drug Discovery and Development), By End-User (Hospitals and Transplant Centers, Biobanks and Research Institutes, Pharmaceutical and Biotechnology Companies, Cell and Tissue Banks, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Cell and Tissue Preservation market size is poised to register 10.32% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cell and Tissue Preservation market across By Preservation Technique (Cryopreservation, Hypothermic Preservation), By Product (Equipment and Consumables, Laboratory Information Management Systems (LIMS), Accessories (vials, containers, labels), By Application (Organ Transplantation:, Regenerative Medicine, Biobanking, Drug Discovery and Development), By End-User (Hospitals and Transplant Centers, Biobanks and Research Institutes, Pharmaceutical and Biotechnology Companies, Cell and Tissue Banks, Others).
The Cell and Tissue Preservation Market is experiencing notable growth and technological advancement in 2024 and beyond, driven by innovations in biobanking, cryopreservation techniques, and tissue engineering strategies aimed at preserving cellular viability, tissue integrity, and biological functionality in biological specimens, organ transplants, and regenerative medicine applications that require long-term storage, transport, or clinical use of human cells, tissues, or organs for research, transplantation, or therapeutic purposes in healthcare systems, academic institutions, and biotechnology companies worldwide. Cell and tissue preservation technologies encompass a diverse array of preservation methods, cryogenic storage systems, and tissue banking solutions designed to maintain cellular viability, prevent cellular damage, and prolong shelf life of biological materials, including cells, tissues, blood products, or organ grafts, under controlled environmental conditions, cryogenic temperatures, or cryoprotectant solutions that minimize ice crystal formation, osmotic stress, or ischemic injury during freezing, thawing, or storage processes, ensuring optimal preservation quality, sample integrity, and functional recovery in biobanking facilities, tissue banks, and cell therapy laboratories engaged in research, clinical trials, or medical treatments involving cell-based therapies, tissue engineering products, or organ transplantation procedures. Key trends include the development of novel cryopreservation agents, biostabilization techniques, and preservation protocols that enhance cell viability, tissue viability, and post-thaw recovery rates in cryopreserved specimens, as well as the integration of automated storage systems, robotics platforms, and liquid handling technologies into biorepository workflows to improve sample management, inventory tracking, and sample retrieval processes in large-scale biobanking operations, personalized medicine initiatives, and population-based biorepositories. Additionally, there is a growing emphasis on regulatory compliance, quality assurance, and accreditation standards that govern biobanking practices, tissue banking operations, and cell therapy manufacturing processes to ensure compliance with Good Manufacturing Practices (GMP), Good Tissue Practices (GTP), and international guidelines for tissue preservation, as well as a growing focus on collaborative partnerships, data sharing initiatives, and biobank networks that facilitate sample sharing, resource pooling, and research collaborations among biorepository facilities, academic research centers, and clinical trial networks, fostering innovation, knowledge exchange, and scientific advancement in biomedicine, regenerative medicine, and precision healthcare worldwide.
Cell and Tissue Preservation Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cell and Tissue Preservation market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cell and Tissue Preservation survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cell and Tissue Preservation industry.
Key market trends defining the global Cell and Tissue Preservation demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Cell and Tissue Preservation Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Cell and Tissue Preservation industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cell and Tissue Preservation companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Cell and Tissue Preservation industry
Leading Cell and Tissue Preservation companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cell and Tissue Preservation companies.
Cell and Tissue Preservation Market Study- Strategic Analysis Review
The Cell and Tissue Preservation market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Cell and Tissue Preservation industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Cell and Tissue Preservation Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Cell and Tissue Preservation Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Cell and Tissue Preservation market segments. Similarly, Strong end-user demand is encouraging Canadian Cell and Tissue Preservation companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Cell and Tissue Preservation market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Cell and Tissue Preservation Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Cell and Tissue Preservation industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Cell and Tissue Preservation market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Cell and Tissue Preservation Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cell and Tissue Preservation in Asia Pacific. In particular, China, India, and South East Asian Cell and Tissue Preservation markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Cell and Tissue Preservation Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Cell and Tissue Preservation Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cell and Tissue Preservation market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cell and Tissue Preservation.
Cell and Tissue Preservation Market Company Profiles
The global Cell and Tissue Preservation market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Avantor Inc, BioLife Solutions Inc, Cesca Therapeutics Inc, Chart Industries Inc, Custom Biogenic Systems, GE Healthcare, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific Inc, VWR International LLC
Recent Cell and Tissue Preservation Market Developments
The global Cell and Tissue Preservation market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Cell and Tissue Preservation Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others
Geographical Segmentation:
Avantor Inc
BioLife Solutions Inc
Cesca Therapeutics Inc
Chart Industries Inc
Custom Biogenic Systems
GE Healthcare
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific Inc
VWR International LLC
Formats Available: Excel, PDF, and PPT
The Cell and Tissue Preservation Market is experiencing notable growth and technological advancement in 2024 and beyond, driven by innovations in biobanking, cryopreservation techniques, and tissue engineering strategies aimed at preserving cellular viability, tissue integrity, and biological functionality in biological specimens, organ transplants, and regenerative medicine applications that require long-term storage, transport, or clinical use of human cells, tissues, or organs for research, transplantation, or therapeutic purposes in healthcare systems, academic institutions, and biotechnology companies worldwide. Cell and tissue preservation technologies encompass a diverse array of preservation methods, cryogenic storage systems, and tissue banking solutions designed to maintain cellular viability, prevent cellular damage, and prolong shelf life of biological materials, including cells, tissues, blood products, or organ grafts, under controlled environmental conditions, cryogenic temperatures, or cryoprotectant solutions that minimize ice crystal formation, osmotic stress, or ischemic injury during freezing, thawing, or storage processes, ensuring optimal preservation quality, sample integrity, and functional recovery in biobanking facilities, tissue banks, and cell therapy laboratories engaged in research, clinical trials, or medical treatments involving cell-based therapies, tissue engineering products, or organ transplantation procedures. Key trends include the development of novel cryopreservation agents, biostabilization techniques, and preservation protocols that enhance cell viability, tissue viability, and post-thaw recovery rates in cryopreserved specimens, as well as the integration of automated storage systems, robotics platforms, and liquid handling technologies into biorepository workflows to improve sample management, inventory tracking, and sample retrieval processes in large-scale biobanking operations, personalized medicine initiatives, and population-based biorepositories. Additionally, there is a growing emphasis on regulatory compliance, quality assurance, and accreditation standards that govern biobanking practices, tissue banking operations, and cell therapy manufacturing processes to ensure compliance with Good Manufacturing Practices (GMP), Good Tissue Practices (GTP), and international guidelines for tissue preservation, as well as a growing focus on collaborative partnerships, data sharing initiatives, and biobank networks that facilitate sample sharing, resource pooling, and research collaborations among biorepository facilities, academic research centers, and clinical trial networks, fostering innovation, knowledge exchange, and scientific advancement in biomedicine, regenerative medicine, and precision healthcare worldwide.
Cell and Tissue Preservation Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cell and Tissue Preservation market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cell and Tissue Preservation survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cell and Tissue Preservation industry.
Key market trends defining the global Cell and Tissue Preservation demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Cell and Tissue Preservation Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Cell and Tissue Preservation industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cell and Tissue Preservation companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Cell and Tissue Preservation industry
Leading Cell and Tissue Preservation companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cell and Tissue Preservation companies.
Cell and Tissue Preservation Market Study- Strategic Analysis Review
The Cell and Tissue Preservation market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Cell and Tissue Preservation industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Cell and Tissue Preservation Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Cell and Tissue Preservation Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Cell and Tissue Preservation market segments. Similarly, Strong end-user demand is encouraging Canadian Cell and Tissue Preservation companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Cell and Tissue Preservation market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Cell and Tissue Preservation Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Cell and Tissue Preservation industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Cell and Tissue Preservation market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Cell and Tissue Preservation Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cell and Tissue Preservation in Asia Pacific. In particular, China, India, and South East Asian Cell and Tissue Preservation markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Cell and Tissue Preservation Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Cell and Tissue Preservation Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cell and Tissue Preservation market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cell and Tissue Preservation.
Cell and Tissue Preservation Market Company Profiles
The global Cell and Tissue Preservation market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Avantor Inc, BioLife Solutions Inc, Cesca Therapeutics Inc, Chart Industries Inc, Custom Biogenic Systems, GE Healthcare, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific Inc, VWR International LLC
Recent Cell and Tissue Preservation Market Developments
The global Cell and Tissue Preservation market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Cell and Tissue Preservation Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Avantor Inc
BioLife Solutions Inc
Cesca Therapeutics Inc
Chart Industries Inc
Custom Biogenic Systems
GE Healthcare
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific Inc
VWR International LLC
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Cell and Tissue Preservation Market Overview and Key Findings, 2024
1.2 Cell and Tissue Preservation Market Size and Growth Outlook, 2021- 2030
1.3 Cell and Tissue Preservation Market Growth Opportunities to 2030
1.4 Key Cell and Tissue Preservation Market Trends and Challenges
1.4.1 Cell and Tissue Preservation Market Drivers and Trends
1.4.2 Cell and Tissue Preservation Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Cell and Tissue Preservation Companies
2. CELL AND TISSUE PRESERVATION MARKET SIZE OUTLOOK TO 2030
2.1 Cell and Tissue Preservation Market Size Outlook, USD Million, 2021- 2030
2.2 Cell and Tissue Preservation Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CELL AND TISSUE PRESERVATION MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CELL AND TISSUE PRESERVATION MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Cell and Tissue Preservation Market, 2025
5.2 Asia Pacific Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Cell and Tissue Preservation Market, 2025
5.5 Europe Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.6 Europe Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Cell and Tissue Preservation Market, 2025
5.8 North America Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.9 North America Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Cell and Tissue Preservation Market, 2025
5.11 South America Pacific Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.12 South America Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Cell and Tissue Preservation Market, 2025
5.14 Middle East Africa Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Cell and Tissue Preservation Market Size Outlook and Revenue Growth Forecasts
6.2 US Cell and Tissue Preservation Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Cell and Tissue Preservation Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Cell and Tissue Preservation Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Cell and Tissue Preservation Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Cell and Tissue Preservation Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Cell and Tissue Preservation Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Cell and Tissue Preservation Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Cell and Tissue Preservation Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Cell and Tissue Preservation Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Cell and Tissue Preservation Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Cell and Tissue Preservation Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Cell and Tissue Preservation Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Cell and Tissue Preservation Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Cell and Tissue Preservation Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Cell and Tissue Preservation Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Cell and Tissue Preservation Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Cell and Tissue Preservation Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Cell and Tissue Preservation Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Cell and Tissue Preservation Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Cell and Tissue Preservation Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Cell and Tissue Preservation Industry Drivers and Opportunities
7. CELL AND TISSUE PRESERVATION MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CELL AND TISSUE PRESERVATION COMPANY PROFILES
8.1 Profiles of Leading Cell and Tissue Preservation Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Avantor Inc
BioLife Solutions Inc
Cesca Therapeutics Inc
Chart Industries Inc
Custom Biogenic Systems
GE Healthcare
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific Inc
VWR International LLC
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Cell and Tissue Preservation Market Overview and Key Findings, 2024
1.2 Cell and Tissue Preservation Market Size and Growth Outlook, 2021- 2030
1.3 Cell and Tissue Preservation Market Growth Opportunities to 2030
1.4 Key Cell and Tissue Preservation Market Trends and Challenges
1.4.1 Cell and Tissue Preservation Market Drivers and Trends
1.4.2 Cell and Tissue Preservation Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Cell and Tissue Preservation Companies
2. CELL AND TISSUE PRESERVATION MARKET SIZE OUTLOOK TO 2030
2.1 Cell and Tissue Preservation Market Size Outlook, USD Million, 2021- 2030
2.2 Cell and Tissue Preservation Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CELL AND TISSUE PRESERVATION MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CELL AND TISSUE PRESERVATION MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Cell and Tissue Preservation Market, 2025
5.2 Asia Pacific Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Cell and Tissue Preservation Market, 2025
5.5 Europe Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.6 Europe Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Cell and Tissue Preservation Market, 2025
5.8 North America Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.9 North America Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Cell and Tissue Preservation Market, 2025
5.11 South America Pacific Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.12 South America Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Cell and Tissue Preservation Market, 2025
5.14 Middle East Africa Cell and Tissue Preservation Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Cell and Tissue Preservation Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Cell and Tissue Preservation Market Size Outlook and Revenue Growth Forecasts
6.2 US Cell and Tissue Preservation Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Cell and Tissue Preservation Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Cell and Tissue Preservation Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Cell and Tissue Preservation Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Cell and Tissue Preservation Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Cell and Tissue Preservation Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Cell and Tissue Preservation Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Cell and Tissue Preservation Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Cell and Tissue Preservation Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Cell and Tissue Preservation Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Cell and Tissue Preservation Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Cell and Tissue Preservation Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Cell and Tissue Preservation Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Cell and Tissue Preservation Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Cell and Tissue Preservation Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Cell and Tissue Preservation Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Cell and Tissue Preservation Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Cell and Tissue Preservation Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Cell and Tissue Preservation Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Cell and Tissue Preservation Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Cell and Tissue Preservation Industry Drivers and Opportunities
7. CELL AND TISSUE PRESERVATION MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CELL AND TISSUE PRESERVATION COMPANY PROFILES
8.1 Profiles of Leading Cell and Tissue Preservation Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Avantor Inc
BioLife Solutions Inc
Cesca Therapeutics Inc
Chart Industries Inc
Custom Biogenic Systems
GE Healthcare
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific Inc
VWR International LLC
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
